CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

TRANSPOSITION OF THE GREAT ARTERIES: OPERATIVE OUTCOME AND MEDIUM TERM FOLLOW-UP

J. Armishaw*, T.L. Gentles, A.L. Calder, P.J. Raudkivi, A.R. Kerr.

Departments of paediatric Cardiology and Cardiothoracic Surgery, Green Lane Hospital, Auckland, New Zealand.

Aim:  To assess the operative outcome and cardiac and neurodevelopmental sequelae in infants with transposition of the great arteries (TGA) undergoing the arterial switch procedure (ASO).

Methods:  A retrospective analysis was undertaken to review surgical outcomes in infants who underwent the ASO for definitive repair of TGA and double outlet right ventricle at Green Lane Hospital between 1984 and 1997.  Cross-sectional review of the subgroup operated on in the calendar years 1996 and 1996 was then undertaken to obtain recent cardiac, growth and neurodevelopmental parameters.

Results:  Operative mortality fell from 27% in the first 3 years of experience to 3% in the last 3 years.  Between January 1995 and December 1996, 48 patients underwent the ASO.  In this subgroup there was one operative death, and one death secondary to pulmonary vascular disease at 15 months of age.  The medium term survival after surgery was therefore 96% at a mean follow-up interval of 17 months.  Six (13%) have important residual cardiac lesions; supra valvular pulmonary stenosis is the most common.  Growth parameters at follow-up are normal, as is the neurodevelopmental progress of all but two survivors, both of whom had pre-operative risk factors for subsequent neurological abnormality.

Conclusions:  In the current era the ASO is a relatively safe procedure with excellent cardiac and neurodevelopmental outcome in the majority of infants.  Of our cohort 96% are alive and 88% are free from death, reintervention and significant neurological sequelae at a mean follow-up of 17 months.

[ Back to 47th ASM Abstract Index ]


Med-E-Serv